Advertisement

Current Cardiology Reports

, 20:137 | Cite as

The Impact of Diet and Lifestyle on Atrial Fibrillation

  • Chrishan J. Nalliah
  • Prashanthan Sanders
  • Jonathan M. Kalman
Invasive Electrophysiology and Pacing (EK Heist, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Invasive Electrophysiology and Pacing

Abstract

Purpose of Review

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans, affecting more than 33 million people globally. Its association with complex, resource intensive medical conditions such as stroke, heart failure and dementia have had profound impacts across existing health care structures. The global prevalence of AF has enjoyed significant growth despite significant improvement in our armamentarium for arrhythmia treatment.

Recent Findings

Efforts aimed at curtailing the incidence, prevalence, or progression of AF have prompted re-evaluation of traditional frameworks for understanding and managing this debilitating disease. It is in this context that focus has shifted toward lifestyle-associated factors such as obesity, hypertension, sleep apnoea, exercise, alcohol and diet, as mechanistic drivers and putative targets for therapy. Compelling evidence exists for weight loss and management of associated risk factors to improve outcomes of AF treatment.

Summary

This review will address the epidemiologic and mechanistic evidence that link lifestyle-associated factors with AF and in light of this analysis evaluate the clinical impacts of their upstream management. Traditional paradigms of AF are shifting in light of emerging evidence, such that risk factor modification has become positioned as the fourth pillar of AF management.

Keywords

Atrial fibrillation Weight loss Risk factor management Diet Exercise Cardio respiratory fitness Alcohol 

Notes

Compliance with Ethical Standards

Conflict of Interest

C.J. Nalliah and J.M. Kalman declare that they have no conflict of interest.

P. Sanders reports grants, non-financial support and other from Medtronic; grants, non-financial support and other from Abbott; grants, non-financial support and other from Boston-Scientific; other from CathRx; and other from Biosense-Webster. He is also supported by a Practitioner Fellowship from the National Health and Medical Research Council of Australia and also by the National Heart Foundation of Australia.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232–8.CrossRefGoogle Scholar
  2. 2.
    Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473–80.CrossRefGoogle Scholar
  3. 3.
    Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the “second factor”. J Am Coll Cardiol. 2009;53:1182–91.CrossRefGoogle Scholar
  4. 4.
    Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JPM, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 7. 2015;66:1–11.CrossRefGoogle Scholar
  5. 5.
    Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90–100.CrossRefGoogle Scholar
  6. 6.
    Lau DH, Middeldorp ME, Brooks AG, Ganesan AN, Roberts-Thomson KC, Stiles MK, et al. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. PLoS One. 2013;8:e76776.CrossRefGoogle Scholar
  7. 7.
    Medi C, Kalman JM, Spence SJ, Teh AW, Lee G, Bader I, et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:1317–24.CrossRefGoogle Scholar
  8. 8.
    Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J. 2006;27:3045–56.CrossRefGoogle Scholar
  9. 9.
    Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med. 2012;172:739–41.CrossRefGoogle Scholar
  10. 10.
    Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.CrossRefGoogle Scholar
  11. 11.
    Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136:583–96.CrossRefGoogle Scholar
  12. 12.
    Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471–7.CrossRefGoogle Scholar
  13. 13.
    Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005;118:489–95.CrossRefGoogle Scholar
  14. 14.
    Knuiman M, Briffa T, Divitini M, Chew D, Eikelboom J, McQuillan B, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014;29:181–90.CrossRefGoogle Scholar
  15. 15.
    Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol. 2010;55:2319–27.CrossRefGoogle Scholar
  16. 16.
    Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc. 2014;3:e000916.CrossRefGoogle Scholar
  17. 17.
    Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29:2227–33.CrossRefGoogle Scholar
  18. 18.
    Karasoy D, Bo Jensen T, Hansen ML, Schmiegelow M, Lamberts M, Gislason GH, et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace. 2013;15:781–6.CrossRefGoogle Scholar
  19. 19.
    Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501–8.CrossRefGoogle Scholar
  20. 20.
    van Rosendael AR, Dimitriu-Leen AC, van Rosendael PJ, et al. Association between posterior left atrial adipose tissue mass and atrial fibrillation. Circ Arrhythm Electrophysiol. 2017;10.Google Scholar
  21. 21.
    Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745–51.CrossRefGoogle Scholar
  22. 22.
    Thanassoulis G, Massaro JM, O'Donnell CJ, Hoffmann U, Levy D, Ellinor PT, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345–50.CrossRefGoogle Scholar
  23. 23.
    Pathak RK, Middeldorp ME, Stolcman S, Willoughby SR, Mahajan R, Lau DH, et al. Aggressive Risk factor REduction STudy: implications for the substrate for atrial fibrillation (ARREST-AF substrate study) (abstract). Circulation. Vol 1322015.Google Scholar
  24. 24.
    O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the multi-ethnic study of atherosclerosis. J Am Soc Hypertens. 2015;9:191–6.CrossRefGoogle Scholar
  25. 25.
    Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, et al. Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control]). Circulation. 2017;135:1788–98.CrossRefGoogle Scholar
  26. 26.
    Santoro F, Di Biase L, Trivedi C, et al. Impact of uncontrolled hypertension on atrial fibrillation ablation outcome. JACC Clinical electrophysiology. 2015;1:164–73.CrossRefGoogle Scholar
  27. 27.
    Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832–9.CrossRefGoogle Scholar
  28. 28.
    Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 1999;100:376–80.CrossRefGoogle Scholar
  29. 29.
    Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation. 2003;107:2926–31.CrossRefGoogle Scholar
  30. 30.
    Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005;45:712–9.CrossRefGoogle Scholar
  31. 31.
    Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J. 2003;24:2090–8.CrossRefGoogle Scholar
  32. 32.
    Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 2002;106:331–6.CrossRefGoogle Scholar
  33. 33.
    Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008;29:1662–9.CrossRefGoogle Scholar
  34. 34.
    Linz D, Hohl M, Ukena C, Mahfoud F, Wirth K, Neuberger HR, et al. Obstructive respiratory events and premature atrial contractions after cardioversion. Eur Respir J. 2015;45:1332–40.CrossRefGoogle Scholar
  35. 35.
    Walters TE, Lee G, Spence S, Larobina M, Atkinson V, Antippa P, et al. Acute atrial stretch results in conduction slowing and complex signals at the pulmonary vein to left atrial junction: insights into the mechanism of pulmonary vein arrhythmogenesis. Circ Arrhythm Electrophysiol. 2014;7:1189–97.CrossRefGoogle Scholar
  36. 36.
    Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7:1263–70.CrossRefGoogle Scholar
  37. 37.
    Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60:172–8.CrossRefGoogle Scholar
  38. 38.
    Linz D, Schotten U, Neuberger HR, Bohm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436–43.CrossRefGoogle Scholar
  39. 39.
    Anter E, Di Biase L, Contreras-Valdes FM, et al. Atrial substrate and triggers of paroxysmal atrial fibrillation in patients with obstructive sleep apnea. Circ Arrhythm Electrophysiol. 2017;10.Google Scholar
  40. 40.
    Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9:321–7.CrossRefGoogle Scholar
  41. 41.
    Shukla A, Aizer A, Holmes D, Fowler S, Park D, Bernstein S, et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis. J Am Coll Cardiol. 2015;1:41–51.Google Scholar
  42. 42.
    Nalliah CJ, Sanders P, Kottkamp H, Kalman JM. The role of obesity in atrial fibrillation. Eur Heart J. 2016;37:1565–72.CrossRefGoogle Scholar
  43. 43.
    Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050–60.CrossRefGoogle Scholar
  44. 44.
    •• Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY Study). J Am Coll Cardiol. 2015;65:2159. This study provides long-term data of the impact of weight loss on arrhythmia freedom. It also highlights that in addition to weight loss, weight stability was also crucial for long term freedom from arrhythmia.–69.CrossRefGoogle Scholar
  45. 45.
    Nalliah CJ, Sanders P, Kalman JM. Surgical weight loss to treat atrial fibrillation risk and progression. Curr Cardiovasc Risk Rep. 2017;11:32.CrossRefGoogle Scholar
  46. 46.
    • Middeldorp ME, Pathak RK, Meredith M, et al. PREVEntion and regReSsive Effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study. Europace. 2018. This study observed that sustained weight loss and risk factor modification can reverse AF profile from perisistent to paroxysmal AF. Google Scholar
  47. 47.
    Winkle RA, Mead RH, Engel G, Kong MH, Fleming W, Salcedo J, et al. Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm. 2017;14:819–27.CrossRefGoogle Scholar
  48. 48.
    Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222–31.CrossRefGoogle Scholar
  49. 49.
    Pathak RK, Evans M, Middeldorp ME, Mahajan R, Mehta AB, Meredith M, et al. Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation: the CENT study. JACC Clin Electrophysiol. 2017;3:436–47.CrossRefGoogle Scholar
  50. 50.
    • Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjostrom L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497–504 This study provides data regarding the impact of dramatic surgical weight loss on incident AF. CrossRefGoogle Scholar
  51. 51.
    H Y, WR M, F L-J, YM C. The impact of bariatric surgery on incidence of atrial fibrillation. Heart Rhythm. 2014;S151.Google Scholar
  52. 52.
    Mostofsky E, Johansen MB, Lundbye-Christensen S, Tjonneland A, Mittleman MA, Overvad K. Risk of atrial fibrillation associated with coffee intake: findings from the Danish Diet, Cancer, and Health study. Eur J Prev Cardiol. 2016;23:922–30.CrossRefGoogle Scholar
  53. 53.
    Klatsky AL, Hasan AS, Armstrong MA, Udaltsova N, Morton C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Permanente J Summer. 2011;15:19–25.Google Scholar
  54. 54.
    Cheng M, Hu Z, Lu X, Huang J, Gu D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol. 2014;30:448–54.CrossRefGoogle Scholar
  55. 55.
    Kang JX, Leaf A. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur J Pharmacol. 1996;297:97–106.CrossRefGoogle Scholar
  56. 56.
    Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res. 2008;57:451–5.CrossRefGoogle Scholar
  57. 57.
    Martino A, Pezzi L, Magnano R, Salustri E, Penco M, Calo L. Omega 3 and atrial fibrillation: where are we? World J Cardiol. 2016;8:114–9.CrossRefGoogle Scholar
  58. 58.
    Rix TA, Joensen AM, Riahi S, Lundbye-Christensen S, Tjonneland A, Schmidt EB, et al. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study. Europace. 2014;16:1554–61.CrossRefGoogle Scholar
  59. 59.
    Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, et al. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012;125:1084–93.CrossRefGoogle Scholar
  60. 60.
    Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation. 2009;120:2315–21.CrossRefGoogle Scholar
  61. 61.
    Nigam A, Talajic M, Roy D, Nattel S, Lambert J, Nozza A, et al. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J Am Coll Cardiol. 2014;64:1441–8.CrossRefGoogle Scholar
  62. 62.
    Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, et al. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (randomized trial to assess efficacy of PUFA for the maintenance of sinus rhythm in persistent atrial fibrillation) trial. J Am Coll Cardiol. 2013;61:463–8.CrossRefGoogle Scholar
  63. 63.
    Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. Jama. 2010;304:2363–72.CrossRefGoogle Scholar
  64. 64.
    Martinez-Gonzalez MA, Toledo E, Aros F, et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevencion con Dieta Mediterranea) trial. Circulation. 2014;130:18–26.CrossRefGoogle Scholar
  65. 65.
    Mattioli AV, Miloro C, Pennella S, Pedrazzi P, Farinetti A. Adherence to Mediterranean diet and intake of antioxidants influence spontaneous conversion of atrial fibrillation. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2013;23:115–21.CrossRefGoogle Scholar
  66. 66.
    Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2960–84.CrossRefGoogle Scholar
  67. 67.
    Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281–9.CrossRefGoogle Scholar
  68. 68.
    Laszlo R, Eick C, Schwiebert M, Schreiner B, Weig HJ, Weretka S, et al. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusion on ion currents in rabbit atrium. Alcohol Clin Exp Res. 2009;33:1697–703.CrossRefGoogle Scholar
  69. 69.
    Chen YC, Chen SA, Chen YJ, Tai CT, Chan P, Lin CI. Effect of ethanol on the electrophysiological characteristics of pulmonary vein cardiomyocytes. Eur J Pharmacol. 2004;483:215–22.CrossRefGoogle Scholar
  70. 70.
    Anadon MJ, Almendral J, Gonzalez P, Zaballos M, Delcan JL, De Guevara JL. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication. Pacing Clin Electrophysiol. 1996;19:1962–7.CrossRefGoogle Scholar
  71. 71.
    Greenspon AJ, Schaal SF. The “holiday heart”: electrophysiologic studies of alcohol effects in alcoholics. Ann Intern Med. 1983;98:135–9.CrossRefGoogle Scholar
  72. 72.
    Qiao Y, Shi R, Hou B, Wu L, Zheng L, Ding L, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4.Google Scholar
  73. 73.
    Maki T, Toivonen L, Koskinen P, Naveri H, Harkonen M, Leinonen H. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol. 1998;82:317–22.CrossRefGoogle Scholar
  74. 74.
    Perman ES. The effect of ethyl alcohol on the secretion from the adrenal medulla in man. Acta Physiol Scand. 1958;44:241–7.CrossRefGoogle Scholar
  75. 75.
    Mandyam MC, Vedantham V, Scheinman MM, Tseng ZH, Badhwar N, Lee BK, et al. Alcohol and vagal tone as triggers for paroxysmal atrial fibrillation. Am J Cardiol. 2012;110:364–8.CrossRefGoogle Scholar
  76. 76.
    Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol as a risk factor for global burden of disease. Eur Addict Res. 2003;9:157–64.CrossRefGoogle Scholar
  77. 77.
    Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J. 2000;16:909–13.CrossRefGoogle Scholar
  78. 78.
    Tanigawa T, Tachibana N, Yamagishi K, Muraki I, Umesawa M, Shimamoto T, et al. Usual alcohol consumption and arterial oxygen desaturation during sleep. Jama. 2004;292:923–5.CrossRefGoogle Scholar
  79. 79.
    Ruigomez A, Johansson S, Wallander MA, Garcia Rodriguez LA. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord. 2005;5:20.CrossRefGoogle Scholar
  80. 80.
    Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118:800–7.CrossRefGoogle Scholar
  81. 81.
    Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2014;7:620–5.CrossRefGoogle Scholar
  82. 82.
    Azarbal F, Stefanick ML, Salmoirago-Blotcher E, et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc. 2014;3.Google Scholar
  83. 83.
    Everett BM, Conen D, Buring JE, Moorthy MV, Lee IM, Albert CM. Physical activity and the risk of incident atrial fibrillation in women. Circulation Cardiovascular quality and outcomes. 2011;4:321–7.CrossRefGoogle Scholar
  84. 84.
    Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100:1037–42.CrossRefGoogle Scholar
  85. 85.
    Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart. 2015;101:1627–30.CrossRefGoogle Scholar
  86. 86.
    Bapat A, Zhang Y, Post WS, Guallar E, Soliman EZ, Heckbert SR, et al. Relation of physical activity and incident atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2015;116:883–8.CrossRefGoogle Scholar
  87. 87.
    Morseth B, Graff-Iversen S, Jacobsen BK, Jorgensen L, Nyrnes A, Thelle DS, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromso study. Eur Heart J. 2016;37:2307–13.CrossRefGoogle Scholar
  88. 88.
    Elliott AD, Maatman B, Emery MS, Sanders P. The role of exercise in atrial fibrillation prevention and promotion: finding optimal ranges for health. Heart Rhythm. 2017;14:1713–20.CrossRefGoogle Scholar
  89. 89.
    Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry ford exercise testing (FIT) project. Circulation. 2015;131:1827–34.CrossRefGoogle Scholar
  90. 90.
    Faselis C, Kokkinos P, Tsimploulis A, Pittaras A, Myers J, Lavie CJ, et al. Exercise capacity and atrial fibrillation risk in veterans: a cohort study. Mayo Clin Proc. 2016;91:558–66.CrossRefGoogle Scholar
  91. 91.
    Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66:985–96.CrossRefGoogle Scholar
  92. 92.
    Malmo V, Nes BM, Amundsen BH, Tjonna AE, Stoylen A, Rossvoll O, et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133:466–73.CrossRefGoogle Scholar
  93. 93.
    Mont L, Sambola A, Brugada J, Vacca M, Marrugat J, Elosua R, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23:477–82.CrossRefGoogle Scholar
  94. 94.
    Elosua R, Arquer A, Mont L, Sambola A, Molina L, Garcia-Moran E, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol. 2006;108:332–7.CrossRefGoogle Scholar
  95. 95.
    Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. Bmj. 1998;316:1784–5.CrossRefGoogle Scholar
  96. 96.
    Molina L, Mont L, Marrugat J, Berruezo A, Brugada J, Bruguera J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10:618–23.CrossRefGoogle Scholar
  97. 97.
    Wilhelm M, Roten L, Tanner H, Wilhelm I, Schmid JP, Saner H. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol. 2011;108:580–5.CrossRefGoogle Scholar
  98. 98.
    Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE, Albert CM. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009;103:1572–7.CrossRefGoogle Scholar
  99. 99.
    Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaelsson K, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34:3624–31.CrossRefGoogle Scholar
  100. 100.
    Baldesberger S, Bauersfeld U, Candinas R, Seifert B, Zuber M, Ritter M, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29:71–8.CrossRefGoogle Scholar
  101. 101.
    Calvo N, Ramos P, Montserrat S, Guasch E, Coll-Vinent B, Domenech M, et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace. 2016;18:57–63.CrossRefGoogle Scholar
  102. 102.
    Takahashi Y, Jais P, Hocini M, Sanders P, Rotter M, Rostock T, et al. Shortening of fibrillatory cycle length in the pulmonary vein during vagal excitation. J Am Coll Cardiol. 2006;47:774–80.CrossRefGoogle Scholar
  103. 103.
    Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–9.CrossRefGoogle Scholar
  104. 104.
    Guasch E, Benito B, Qi X, Cifelli C, Naud P, Shi Y, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62:68–77.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Chrishan J. Nalliah
    • 1
  • Prashanthan Sanders
    • 2
  • Jonathan M. Kalman
    • 1
  1. 1.The Department of Cardiology, Royal Melbourne Hospital and the Department of MedicineUniversity of MelbourneMelbourneAustralia
  2. 2.Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI)University of Adelaide and Royal Adelaide HospitalAdelaideAustralia

Personalised recommendations